Reaction profile

The FDA adverse-event record for omentum inflammation

Name: Omentum inflammation - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

23 FDA reports name omentum inflammation, a lower-volume reaction in the CVM extract (VeDDRA 254). Plate stamps and neighbourhood peers follow.

#2114 of 2,481
by report volume (all reactions): 23
reports citing this reaction: 56.5%
death-coded share: Dog
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Omentum inflammation has 23 reports now versus 22 in that prior snapshot: 1 more (4.5%).

Report change: +1
Death-coded reports: +0
Death-coded share: −2.6 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Omentum inflammation changes

FDA AER · VeDDRA plate

Code 254 VOL-TRACE

VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

VOL-TRACE 23 reports
DEATH-HOT 56.5%
LOWER-Q #2114/2481
PHOTO-FINISH Anal oedema
SPECIES-DOG Dog · 19
DRUG-LEAD Deracoxib · 6
DESK-WIDE 14 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: Anal oedema (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Omentum inflammation

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

FDA AER report volume · neighbourhood around Omentum inflammation

Omentum inflammation: high death-coded share in the FDA AER plate

Signature read: Omentum inflammation's 56.5% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 23 named reports in the openFDA extract. Death-coded share is upper-third: 13 of 23 reports (56.5% of named reports). Nearest volume peer: Anal oedema (±0 reports). Lead species Dog (19). Lead co-reported drug Deracoxib (6).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 19

Cat 4

Breeds Most Affected

Retriever - Labrador 7

Domestic Shorthair 3

Terrier - Bull - American Pit 2

Dachshund (unspecified) 1

Schnauzer - Miniature 1

Dalmatian 1

Spaniel - Cocker English 1

Doberman Pinscher 1

Saint Bernard Dog 1

Setter - English 1

Associated Drugs

Deracoxib 6

Firocoxib 4

Isoflurane 4

Tramadol 3

Gabapentin 3

Carprofen 3

Buprenorphine 3

Milbemycin Oxime + Spinosad 2

Enrofloxacin 2

Fipronil 2

Ketamine 2

Meloxicam 2

Maropitant Citrate 2

Hydrolyzed Protein Diet 2

Spinosad 1

Emodepside + Praziquantel 1

Buprenorphine Hcl And Naloxone Hcl 1

Distemper 1

Feline Leukemia 1

Subcutaneous Fluids 1

What to do with this reaction

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Omentum inflammation (#2114 of 2,481 by report volume); death-coded 56.5%. PlainBreed reaction plate · death-coded share stamp 56.5% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →